Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer

BACKGROUND: Little is known regarding the clinicopathologic characteristics, oncologic outcomes, and treatment strategies that could be ascribed to BRCA mutation in early-onset triple-negative breast cancer (eTNBC). METHODS: eTNBC patients who underwent BRCA genetic testing were derived from our cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Fugui, He, Min, Huang, Liang, Lang, Guantian, Hu, Xin, Shao, Zhimin, Di, Genhong, Cao, Ayong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829963/
https://www.ncbi.nlm.nih.gov/pubmed/33505905
http://dx.doi.org/10.3389/fonc.2020.574813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829963/
https://www.ncbi.nlm.nih.gov/pubmed/33505905
http://dx.doi.org/10.3389/fonc.2020.574813

Ejemplares similares